New York, New York--(Newsfile Corp. - February 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.SO WHAT: If you purchased agilon securities during the Class Period you may be entitled to compensation without payment of any ou ...

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ag ...

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against agilon health, inc. (NYSE: AGL) for allegedly issuing misleading statements and failing to disclose critical information during the class period from February 26, 2025, to August 4, 2025 [1]. Allegations - The lawsuit claims that the defendants provided guidance for 2025 that they knew or should have known was unrealistic due to significant industry challenges [1]. - It is alleged that the defendants overstated the immediate financial benefits from strategic actions taken by agilon to mitigate risks [1]. - Consequently, the statements made by the defendants regarding agilon's business, operations, and future prospects were materially false and misleading [1]. Class Action Details - The deadline for shareholders to register for the class action is March 2, 2026 [1]. - Shareholders who purchased AGL shares during the specified class period are encouraged to register for potential lead plaintiff appointment, although it is not necessary to participate in any recovery [1]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [1].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. (AGL) for alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by March 2, 2026 [1] Summary by Relevant Sections Legal Action - A federal securities class action has been filed against agilon health, alleging that the company and its executives made false and misleading statements regarding their financial guidance and business operations [1] - The complaint claims that the defendants issued guidance for 2025 that they knew or should have known was unattainable due to industry headwinds [1] - The lawsuit also alleges that the defendants overstated the financial impact of strategic actions taken to reduce risk, leading to materially false statements about the company's prospects [1] Financial Impact - On August 4, 2025, agilon health reported its second-quarter results, indicating that industry challenges were more severe than previously anticipated, and subsequently suspended its full-year 2025 financial guidance [1] - Following this announcement, agilon health's stock price dropped by 51.5% on August 5, 2025, reflecting the market's reaction to the revised outlook [1] Class Action Participation - The lead plaintiff in the class action will be the investor with the largest financial interest who is also typical of the class members, overseeing the litigation on behalf of the group [1] - Any member of the class can apply to serve as lead plaintiff or choose to remain an absent class member, with their ability to recover not affected by this decision [1]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to alleged violations of federal securities laws, encouraging affected investors to contact them for legal options [2][4]. Group 1: Legal Investigation and Claims - The law firm is looking into claims against agilon health for misleading statements and failure to disclose critical information regarding the company's financial guidance and operational challenges [4]. - Investors who purchased agilon health securities between February 26, 2025, and August 4, 2025, are reminded of the March 2, 2026, deadline to seek the role of lead plaintiff in a federal securities class action [2][6]. Group 2: Company Performance and Stock Impact - On August 4, 2025, agilon health announced the suspension of its full-year 2025 financial guidance, leading to a significant stock price drop of 51.5% on August 5, 2025 [5]. - The company's Executive Chair acknowledged that industry headwinds were more severe than previously anticipated, indicating challenges in achieving the previously issued financial guidance [5]. Group 3: Firm Background and Recovery - Faruqi & Faruqi, LLP has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995, with offices across multiple states [3]. - The firm encourages anyone with information regarding agilon health's conduct to come forward, including whistleblowers and former employees [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to allegations of violations of federal securities laws, specifically regarding misleading statements and guidance issued by the company [2][4]. Group 1: Legal Investigation - The law firm is encouraging agilon health investors who suffered losses exceeding $50,000 between February 26, 2025, and August 4, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against agilon health, with a deadline of March 2, 2026, for investors to seek the role of lead plaintiff [2][5]. - The complaint alleges that agilon health and its executives made false and misleading statements regarding the company's financial guidance and the impact of strategic actions taken to reduce risk [4]. Group 2: Company Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. - The firm is actively seeking information from whistleblowers, former employees, and shareholders regarding agilon health's conduct [6].

Core Viewpoint - A class action lawsuit has been filed against Agilon Health, Inc. for allegedly making false and misleading statements regarding its financial guidance and business operations during the Class Period from February 26, 2025, to August 4, 2025 [3][7]. Allegation Details - The lawsuit claims that Agilon's management issued guidance for 2025 that was unrealistic given known industry challenges [3]. - It is alleged that the company overstated the positive financial impact from strategic actions taken to mitigate risks [3]. - As a result, statements made by the defendants regarding Agilon's business and prospects were materially false and misleading [3]. Next Steps - Investors who acquired Agilon shares and suffered losses are encouraged to contact the law firm for more information and to discuss their rights [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is March 2, 2026 [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to alleged violations of federal securities laws, encouraging affected investors to contact them for legal options [2][4]. Group 1: Legal Investigation - The law firm is reminding investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against agilon health [2]. - The complaint alleges that agilon health and its executives made false or misleading statements regarding the company's financial guidance for 2025, which they knew was unattainable due to industry challenges [4]. Group 2: Financial Impact - On August 4, 2025, agilon health announced the suspension of its full-year 2025 financial guidance, leading to a significant stock price drop of 51.5% on August 5, 2025 [5]. - The complaint claims that the defendants overstated the financial benefits from strategic actions taken to mitigate risks, resulting in materially false statements about the company's business and prospects [4]. Group 3: Firm Background - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its establishment in 1995 and has offices in New York, Pennsylvania, California, and Georgia [3].

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased agilon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fe ...

Core Viewpoint - The complaint against agilon health alleges that the company and its executives violated federal securities laws by making false or misleading statements and failing to disclose significant risks related to their 2025 guidance and financial impacts from strategic actions taken to reduce risk [2]. Group 1 - The complaint claims that the defendants recklessly issued guidance for 2025, which they knew or should have known was unattainable due to material industry headwinds [2]. - It is alleged that the defendants materially overstated the immediate positive financial impact from strategic actions taken by agilon to mitigate risk [2]. - As a result of these actions, the statements made by the defendants regarding agilon's business, operations, and prospects were materially false and misleading at all times [2]. Group 2 - The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class, who directs and oversees the litigation on behalf of the putative class [3]. - Any member of the putative class has the option to move the Court to serve as lead plaintiff or may choose to remain an absent class member without affecting their ability to share in any recovery [3]. Group 3 - Faruqi & Faruqi, LLP encourages individuals with information regarding agilon health's conduct to contact the firm, including whistleblowers and former employees [4].